Sunil Verma, SVP and Global Head of Oncology at AstraZeneca, has lived a life defined by reinvention. Born in Zambia, raised across Africa, India, and Canada, he was accepted to medical school at 19, became one of the most respected breast cancer oncologists in Canada, built a cancer center in Calgary from the ground up, and then left academia entirely to help write the next chapters of oncology at AstraZeneca alongside the late Jose Baselga.

In this conversation, Sean Khozin and Sunil explore the formative experiences that shaped his worldview and leadership philosophy, what it means to build healthcare infrastructure around the concept of healing, and how AstraZeneca's oncology portfolio expanded from a single asset into one of the most consequential in the world.

They go deep on the science and strategy behind antibody-drug conjugates (ADCs), the frontier of ADC and immunotherapy combinations, and a distinction Sunil considers the true next frontier of the field: the difference between precision medicine and genuinely personalized medicine, where patient values are matched to therapeutic value.